JUSTIN FIELDS: Open Payments
NPI 1003013723 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 27 payments from 15 companies in 2025. Trend: 2023 $296 · 2024 $280 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 2 | $30 |
| ABBVIE INC. | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
Products named: GEMTESA, FANAPT, JARDIANCE, MOUNJARO, NURTEC ODT, UBRELVY, Dexcom G6 Transmitter, WATCHMAN Access System.
Industry payments across OK — which companies pay providers there.
